Potential mechanisms of CD133 in cancer stem cells

Jae Woo Jang, Yeonhwa Song, Se Hyuk Kim, Joon Kim, Haeng Ran Seo

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) have emerged as an underlying cause of cancer relapse and resistance to treatment. Initially, biomarkers were used to identify and isolate distinct cell populations. Several CSC markers have been identified from many types of tumors, and these markers are also being used for isolation and enrichment of CSCs. Cluster of differentiation CD133 is a well-characterized CSC marker, and it is involved in tumor cell proliferation, metastasis, tumorigenesis, and recurrence, as well as chemo- and radio-resistance. However, the mechanisms involved in CD133-mediated induction of CSC properties have not yet been elucidated. Here, we introduce and summarize the functions of CD133 in CSCs and suggest new mechanisms that may be of note in our approach to developing novel cancer therapies.

Original languageEnglish
Pages (from-to)25-29
Number of pages5
JournalLife Sciences
Volume184
DOIs
Publication statusPublished - 2017 Sep 1

Fingerprint

Neoplastic Stem Cells
Stem cells
Recurrence
Neoplasms
Cell proliferation
Biomarkers
Tumor Biomarkers
Radio
Tumors
Carcinogenesis
Cells
Cell Proliferation
Neoplasm Metastasis
Population

Keywords

  • Autophagy
  • Cancer stem cells (CSCs)
  • CD133
  • EGFR
  • Lipid metabolism
  • PI3K
  • Reactive oxygen species (ROS)
  • Src

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Potential mechanisms of CD133 in cancer stem cells. / Jang, Jae Woo; Song, Yeonhwa; Kim, Se Hyuk; Kim, Joon; Seo, Haeng Ran.

In: Life Sciences, Vol. 184, 01.09.2017, p. 25-29.

Research output: Contribution to journalReview article

Jang, Jae Woo ; Song, Yeonhwa ; Kim, Se Hyuk ; Kim, Joon ; Seo, Haeng Ran. / Potential mechanisms of CD133 in cancer stem cells. In: Life Sciences. 2017 ; Vol. 184. pp. 25-29.
@article{36d89340109743f593bf08ed4af1b6b4,
title = "Potential mechanisms of CD133 in cancer stem cells",
abstract = "Cancer stem cells (CSCs) have emerged as an underlying cause of cancer relapse and resistance to treatment. Initially, biomarkers were used to identify and isolate distinct cell populations. Several CSC markers have been identified from many types of tumors, and these markers are also being used for isolation and enrichment of CSCs. Cluster of differentiation CD133 is a well-characterized CSC marker, and it is involved in tumor cell proliferation, metastasis, tumorigenesis, and recurrence, as well as chemo- and radio-resistance. However, the mechanisms involved in CD133-mediated induction of CSC properties have not yet been elucidated. Here, we introduce and summarize the functions of CD133 in CSCs and suggest new mechanisms that may be of note in our approach to developing novel cancer therapies.",
keywords = "Autophagy, Cancer stem cells (CSCs), CD133, EGFR, Lipid metabolism, PI3K, Reactive oxygen species (ROS), Src",
author = "Jang, {Jae Woo} and Yeonhwa Song and Kim, {Se Hyuk} and Joon Kim and Seo, {Haeng Ran}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.lfs.2017.07.008",
language = "English",
volume = "184",
pages = "25--29",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Potential mechanisms of CD133 in cancer stem cells

AU - Jang, Jae Woo

AU - Song, Yeonhwa

AU - Kim, Se Hyuk

AU - Kim, Joon

AU - Seo, Haeng Ran

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Cancer stem cells (CSCs) have emerged as an underlying cause of cancer relapse and resistance to treatment. Initially, biomarkers were used to identify and isolate distinct cell populations. Several CSC markers have been identified from many types of tumors, and these markers are also being used for isolation and enrichment of CSCs. Cluster of differentiation CD133 is a well-characterized CSC marker, and it is involved in tumor cell proliferation, metastasis, tumorigenesis, and recurrence, as well as chemo- and radio-resistance. However, the mechanisms involved in CD133-mediated induction of CSC properties have not yet been elucidated. Here, we introduce and summarize the functions of CD133 in CSCs and suggest new mechanisms that may be of note in our approach to developing novel cancer therapies.

AB - Cancer stem cells (CSCs) have emerged as an underlying cause of cancer relapse and resistance to treatment. Initially, biomarkers were used to identify and isolate distinct cell populations. Several CSC markers have been identified from many types of tumors, and these markers are also being used for isolation and enrichment of CSCs. Cluster of differentiation CD133 is a well-characterized CSC marker, and it is involved in tumor cell proliferation, metastasis, tumorigenesis, and recurrence, as well as chemo- and radio-resistance. However, the mechanisms involved in CD133-mediated induction of CSC properties have not yet been elucidated. Here, we introduce and summarize the functions of CD133 in CSCs and suggest new mechanisms that may be of note in our approach to developing novel cancer therapies.

KW - Autophagy

KW - Cancer stem cells (CSCs)

KW - CD133

KW - EGFR

KW - Lipid metabolism

KW - PI3K

KW - Reactive oxygen species (ROS)

KW - Src

UR - http://www.scopus.com/inward/record.url?scp=85022061743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022061743&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2017.07.008

DO - 10.1016/j.lfs.2017.07.008

M3 - Review article

VL - 184

SP - 25

EP - 29

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

ER -